drugset / Trial / NCT01240785

Metformin Versus Insulin in Gestational Diabetes

NCT01240785

Phase 4 Completed 221 enrolled Turku University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Gestational diabetes is traditionally treated with insulin. Metformin is a peroral drug used worldwide in the treatment of type 2 diabetes and also in a few studies on patients with gestational diabetes. The investigators aim is to compare insulin and metformin in the treatment of gestational diabetes. The investigators hypothesis is that there is no difference between insulin and metformin treated mothers in the main outcome criteria (birth weight, neonatal complications).

Timeline

Start
2006-06
Primary completion
2011-01
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic Subcutaneous
Comparator Metformin Small molecule 1 g Oral

Indications